Profile
NCNA VRTX ALNY REGN ARGX SGEN
Company Name NuCana plc Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $26.84M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.02K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Hugh Stephen Griffith Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
NCNA VRTX ALNY REGN ARGX SGEN
Quant Rating Score 3 4 1 4 4 3
Quant Rating Neutral Buy Strong Sell Buy Buy Neutral
Trading
NCNA VRTX ALNY REGN ARGX SGEN
Last Close $4.42 $391.36 $461.24 $575.06 $752.32 $228.74
High 52 $4.7 $516.74 $482.13 $1150.19 $768 $228.74
Low 52 $0.03 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -5.96 % -24.26 % -4.33 % -50 % -2.04 % 0 %
Price vs. 52 Week Low 14633.3 % 6.77 % 105.38 % 19.08 % 44.74 % 0 %
Total Return
NCNA VRTX ALNY REGN ARGX SGEN
1 Month Return 18.5 % -0.36 % 2.75 % -0.92 % 15.06 % 0 %
3 Month Return 3481.85 % -11.46 % 49.37 % 12.99 % 39.14 % 0 %
6 Month Return 432.53 % -23.82 % 82.16 % -15.15 % 22.49 % 0 %
9 Month Return 245.31 % -16.6 % 87.05 % -22.29 % 17.86 % 0 %
YTD Return 271.43 % -2.82 % 96.01 % -19.27 % 22.33 % 0 %
1 Year Return 19.46 % -18.68 % 68.05 % -49.85 % 44.06 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NCNA VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -93.59 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
NCNA VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM - 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -195.78 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -580.99 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -277.46 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 95.32 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 159.62 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM - 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -12761.69 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM - 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM - 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM - 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.76 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -0.77 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 32.64 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM - 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.07 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -12761.69 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -0.99 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -0.17 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -0.17 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
NCNA VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 0% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.02B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.02B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -3.27 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
NCNA VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.01B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.01B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.01B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
NCNA VRTX ALNY REGN ARGX SGEN
Net Income $-0.02B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.2
AARD Aardvark Therapeutics, Inc. Common Stock 10.99
ABCL AbCellera Biologics Inc. 4.565
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.635
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.255
ABPWW 0.046281
ABSI Absci Corporation 2.555
ABUS Arbutus Biopharma Corporation 4.425
ABVC ABVC BioPharma, Inc. 2.8645
ABVX Abivax SA American Depositary Shares 81.05
ACAD ACADIA Pharmaceuticals Inc. 24.2
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7602
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.965
ACIU AC Immune SA 2.46
Unlock